Hi Kelly, Since what you want to treat will usually be a fibrin sheath that is outside of the catheter, you will want the tPA to exit the catheter tip. The tPA left in port/catheter will do no good. So if you are worried about bleeding for a patient, this might be an issue. Although what you will administer is about 2% of the MI dose, so it's not much. I do think problems could arise, but I've never seen or heard of an example in our dept since 1989. We routinely use tPA for thrombotic occlusions.
Mats in Stockholm Den 06-09-28 22.13, skrev "Kelly Murphy" <[EMAIL PROTECTED]>: > I don't know about our policies, but my question is in > addition to yours - if TPA is used to declot a line > properly, it should never enter the patient's > bloodstream, right? So, there shouldn't be any > contraindications, right? This isn't to argue, I > honestly want to know. > Thanks, > Kelly > > --- Moore Beverly <[EMAIL PROTECTED]> wrote: > >> TPA has the following contraindications: >> a. Active internal bleeding >> b. History of recent CVA (2 months or less) >> c. Intracranial or or intraspinal bleeding >> d. AV malformations or aneurysm >> e. Recent (2 months or less) intracranial or >> intraspinal surgery >> f. Uncontrolled hypertension >> Do you list any complications of Cathflo Activase >> in your policies? I >> know the salesman says there are no >> contraindications, Most of the >> doctors around here will not order if they are >> worried about bleeding. >> I don't have a package insert here at this time to >> read. >> > > > __________________________________________________ > Do You Yahoo!? > Tired of spam? Yahoo! Mail has the best spam protection around > http://mail.yahoo.com > >
